Stay updated on Adjuvant Pembrolizumab in Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Adjuvant Pembrolizumab in Esophageal Cancer Clinical Trial page.

Latest updates to the Adjuvant Pembrolizumab in Esophageal Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page revision label was updated from v3.6.5 to v3.6.6, indicating a minor metadata update to the study record page. This reflects a background editorial/update rather than changes to the study data or eligibility.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, indicating a minor metadata update to the page.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision label updated from v3.6.3 to v3.6.4, indicating a newer page version. This appears to be a minor technical update to the page rather than a change to study details.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.3, indicating a newer published version of the study record. This is a maintenance update that does not modify the study data or other substantive content on the page.SummaryDifference0.1%

- Check88 days agoChange DetectedThe study record now indicates that recruitment is closed and no longer looking for participants. Additionally, new help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), the Intervention/Treatment label was reformatted, and the revision version updated to v3.6.0.SummaryDifference0.4%

- Check95 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, reflecting an editorial update to the page metadata.SummaryDifference0.1%

Stay in the know with updates to Adjuvant Pembrolizumab in Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjuvant Pembrolizumab in Esophageal Cancer Clinical Trial page.